Extensive post-translational modification of active and inactivated forms of endogenous p53

Molecular and Cellular Proteomics

Volumn 13, Issue 1, 2014, Pages 1-17

  DeHart, Caroline J ^a   Chahal, Jasdave S ^a,b   Flint, S J ^a   Perlman, David H ^a  

^a PRINCETON UNIVERSITY   (United States)

^b WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; ETOPOSIDE; LYSINE; PROTEIN P53; SERINE; THREONINE; VIRUS LARGE T ANTIGEN;

ACETYLATION; AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL LYSATE; CONTROLLED STUDY; DNA BINDING; FIBROBLAST; HUMAN; HUMAN CELL; IMMUNOAFFINITY CHROMATOGRAPHY; IN VITRO STUDY; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN ISOLATION; PROTEIN LOCALIZATION; PROTEIN METHYLATION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN PURIFICATION; SIMIAN VIRUS 40; STEADY STATE; TANDEM MASS SPECTROMETRY; UBIQUITINATION; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; WHOLE CELL;

ACETYLATION; ADENOVIRUS E1B PROTEINS; ANIMALS; CERCOPITHECUS AETHIOPS; COS CELLS; DNA-BINDING PROTEINS; FIBROBLASTS; HUMANS; METHYLATION; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEOLYSIS; TUMOR SUPPRESSOR PROTEIN P53; UBIQUITIN-PROTEIN LIGASES;

EID: 84891762808     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M113.030254     Document Type: Article

References (143)

1. Lane, D. P., and Crawford, L. V. (1979) T antigen is bound to a host protein in SY40-transformed cells. Nature 278, 261-263
2. Linzer, D. I., and Levine, A. J. (1979) Characterization of a 54K Dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells. Cell 17, 43-52
3. Vogelstein, B., Lane, D., and Levine, A. J. (2000) Surfing the p53 network. Nature 408, 307-310
4. Harris, S. L., and Levine, A. J. (2005) The p53 pathway: positive and negative feedback loops. Oncogene 24, 2899-2908
5. Meek, D. W., and Anderson, C. W. (2009) Posttranslational modification of p53: cooperative integrators of function. Cold Spring Harb. Perspect. Biol. 1(6), a000950
6. Levine, A. J., and Oren, M. (2009) The first 30 years of p53: growing ever more complex. Nat. Rev. Cancer 9, 749-758
7. Gottlieb, E., and Vousden, K. H. (2010) p53 regulation of metabolic pathways. Cold Spring Harb. Perspect. Biol. 2(4), a001040
8. Green, D. R., and Chipuk, J. E. (2006) p53 and metabolism: inside the TIGAR. Cell 126, 30-32
9. Riley, T., Sontag, E., Chen, P., and Levine, A. (2008) Transcriptional control of human p53-regulated genes. Nat. Rev. Mol. Cell Biol. 9(5), 402-412
10. Vousden, K. H., and Prives, C. (2009) Blinded by the light: the growing complexity of p53. Cell 137, 413-431
11. Menendez, D., Inga, A., and Resnick, M. A. (2009) The expanding universe of p53 targets. Nat. Rev. Cancer 9, 724-737
12. Vogelstein, B., Fearon, E. R., Kern, S. E., Hamilton, S. R., Preisinger, A. C., Nakamura, Y., and White, R. (1989) Allelotype of colorectal carcinomas. Science 244, 207-211
13. Hollstein, M., Sidransky, D., Vogelstein, B., and Harris, C. C. (1991) p53 mutations in human cancers. Science 253, 49-53
14. Joerger, A. C., and Fersht, A. R. (2007) Structural biology of the tumor suppressor p53 and cancer-associated mutants. Adv. Cancer Res. 97, 1-23
15. Olivier, M., Eeles, R., Hollstein, M., Khan, M. A., Harris, C. C., and Hainaut, P. (2002) The IARC TP53 database: new online mutation analysis and recommendation to users. Hum. Mutat. 19, 607-614
16. Hock, A., and Vousden, K. H. (2010) Regulation of the p53 pathway by ubiquitin and related proteins. Int. J. Biochem. Cell Biol. 42, 1618-1621
17. Brooks, C. L., and Gu, W. (2011) p53 regulation by ubiquitin. FEBS Lett. 585, 2803-2809
18. Okamoto, K., Taya, Y., and Nakagama, H. (2009) Mdmx enhances p53 ubiquitination by altering the substrate preference of the Mdm2 ubiquitin ligase. FEBS Lett. 583, 2710-2714
19. Wade, M., Wang, Y. V., and Wahl, G. M. (2010) The p53 orchestra: Mdm2 and Mdmx set the tone. Trends Cell Biol. 20, 299-309
20. Brooks, C. L., and Gu, W. (2011) The impact of acetylation and deacetylation on the p53 pathway. Protein Cell 2, 456-462
21. Horn, H. F., and Vousden, K. H. (2007) Coping with stress: multiple ways to activate p53. Oncogene 26, 1306-1316
22. Green, D. R., and Kroemer, G. (2009) Cytoplasmic functions of the tumour suppressor p53. Nature 458, 1127-1130
23. Moll, U. M., Wolff, S., Speidel, D., and Deppert, W. (2005) Transcriptionindependent pro-apoptotic functions of p53. Curr. Opin. Cell. Biol. 17, 631-636
24. Murray-Zmijewski, F., Slee, E. A., and Lu, X. (2008) A complex barcode underlies the heterogeneous response of p53 to stress. Nat. Rev. Mol. Cell Biol. 9, 702-712
25. Kannan, K., Amariglio, N., Rechavi, G., Jakob-Hirsch, J., Kela, I., Kaminski, N., Getz, G., Domany, E., and Givol, D. (2001) DNA microarrays identification of primary and secondary target genes regulated by p53. Oncogene 20, 2225-2234
26. Fridman, J. S., and Lowe, S. W. (2003) Control of apoptosis by p53. Oncogene 22, 9030-9040
27. Wei, C. L., Wu, Q., Vega, V. B., Chiu, K. P., Ng, P., Zhang, T., Shahab, A., Yong, H. C., Fu, Y., Weng, Z., Liu, J., Zhao, X. D., Chew, J. L., Lee, Y. L., Kuznetsov, V. A., Sung, W. K., Miller, L. D., Lim, B., Liu, E.T., Yu, Q., Ng, H. H., and Ruan, Y. (2006) A global map of p53 transcription-factor binding sites in the human genome. Cell 124, 207-219
28. Kruse, J. P., and Gu, W. (2009) Modes of p53 regulation. Cell 137, 609-622
29. Dai, C., and Gu, W. (2010) p53 post-translational modification: deregulated in tumorigenesis. Trends Mol. Med. 16, 528-536
30. Loewer, A., Batchelor, E., Gaglia, G., and Lahav, G. (2010) Basal dynamics of p53 reveal transcriptionally attenuated pulses in cycling cells. Cell 142, 89-100
31. Taira, N., and Yoshida, K. (2012) Post-translational modifications of p53 tumor suppressor: determinants of its functional targets. Histol. Histopathol. 27, 437-443
32. Gu, B., and Zhu, W. G. (2012) Surf the post-translational modification network of p53 regulation. Int. J. Biol. Sci. 8, 672-684
33. Feng, L., Lin, T., Uranishi, H., Gu, W., and Xu, Y. (2005) Functional analysis of the roles of posttranslational modifications at the p53 C terminus in regulating p53 stability and activity. Mol. Cell. Biol. 25(13), 5389-5395
34. Krummel, K. A., Lee, C. J., Toledo, F., and Wahl, G. M. (2005) The C-terminal lysines fine-tune P53 stress responses in a mouse model but are not required for stability control or transactivation. Proc. Natl. Acad. Sci. U.S.A. 102(29), 10188-10193
35. Toledo, F., and Wahl, G. M. (2006) Regulating the p53 pathway: in vitro hypotheses, in vivo veritas. Nat. Rev. Cancer 6, 909-923
36. Olsson, A., Manzl, C., Strasser, A., and Villunger, A. (2007) How important are post-translational modifications in p53 for selectivity in target-gene transcription and tumour suppression? Cell Death Differ. 14, 1561-1575
37. Scoumanne, A., and Chen, X. (2008) Protein methylation: a new mechanism of p53 tumor suppressor regulation. Histol. Histopathol. 23, 1143-1149
38. Candau, R., Scolnick, D. M., Darpino, P., Ying, C. Y., Halazonetis, T. D., and Berger, S. L. (1997) Two tandem and independent sub-activation domains in the amino terminus of p53 require the adaptor complex for activity. Oncogene 15, 807-816
39. Zhu, J., Zhang, S., Jiang, J., and Chen, X. (2000) Definition of the p53 functional domains necessary for inducing apoptosis. J. Biol. Chem. 275(51), 39927-39934
40. Ayed, A., Mulder, F. A., Yi, G. S., Lu, Y., Kay, L. E., and Arrowsmith, C. H. (2001) Latent and active p53 are identical in conformation. Nat. Struct. Biol. 8, 756-760
41. Lee, J. T., and Gu, W. (2010) The multiple levels of regulation by p53 ubiquitination. Cell Death Differ. 17, 86-92
42. Wang, Y., and Prives, C. (1995) Increased and altered DNA binding of human p53 by S and G2/M but not G1 cyclin-dependent kinases. Nature 376, 88-91
43. Fraser, J. A., Madhumalar, A., Blackburn, E., Bramham, J, Walkinshaw, M. D., Verma, C., and Hupp, T. R. (2010) A novel p53 phosphorylation site within the MDM2 ubiquitination signal: II. A model in which phosphorylation at SER269 induces a mutant conformation to p53. J. Biol. Chem. 285(48), 37773-37786
44. Maclaine, N. J., and Hupp, T. R. (2010) The regulation of p53 protein function by phosphorylation. In p53 (Ayed, A. and Hupp, T. R., eds.) Landes Bioscience, Austin, TX 53-64
45. Waterman, M. J., Stavridi, E. S., Waterman, J. L., and Halazonetis, T. D. (1998) ATM-dependent activation of p53 involves dephosphorylation and association with 14-3-3 proteins. Nat. Genet. 19, 175-178
46. Rajagopalan, S., Jaulent, A. M., Wells, M., Veprintsev, D. B., and Fersht, A. R. (2008) 14-3-3 activation of DNA binding of p53 by enhancing its association into tetramers. Nucleic Acids Res. 36, 5983-5991
47. Liu, Q., Kaneko, S., Yang, L., Feldman, R. I., Nicosia, S. V., Chen, J., and Cheng, J. Q. (2004) Aurora-A abrogation of p53 binding and transactivation activity by phosphorylation of serine 215. J. Biol. Chem. 279(50), 52175-52182
48. Fraser, J. A., Vojtesek, B., and Hupp, T. R. (2010) A novel p53 phosphorylation site within the MDM2 ubiquitination signal: I. Phosphorylation at SER269 in vivo is linked to inactivation of p53 function. J. Biol. Chem. 285, 37762-37772
49. Wu, L., Ma, C. A., Zhao, Y., and Jain, A. (2011) Aurora B interacts with NIR-p53, leading to p53 phosphorylation in its DNA-binding domain and subsequent functional suppression. J. Biol. Chem. 286(3), 2236-2244
50. Bech-Otschir, D., Kraft, R., Huang, X., Henklein, P., Kapelari, B., Pollmann, C., and Dubiel, W. (2001) COP9 signalsome-specific phosphorylation targets p53 to degradation by the ubiquitin system. EMBO J. 20, 1630-1639
51. Gully, C. P., Velazquez-Torres, G., Shin, J. H., Fuentes-Mattei, E., Wang, E., Carlock, C., Chen, J., Rothenberg, D., Adams, H. P., Choi, H. H., Guma, S., Phan, L., Chou, P. C., Su, C. H., Zhang, F., Chen, J. S., Yang, T. Y., Yeung, S. C., and Lee, M. H. (2012) Aurora B kinase phosphorylates and instigates degradation of p53. Proc. Natl. Acad. Sci. U.S.A. 109(24), E1513-E1522
52. Ullrich, S. J., Sakaguchi, K., Lees-Miller, S. P., Fiscella, M., Mercer, W. E., Anderson, C. W., and Appella, E. (1993) Phosphorylation at Ser-15 and Ser-392 in mutant p53 molecules from human tumors is altered compared to wild-type p53. Proc. Natl. Acad. Sci. U.S.A. 90(13), 5954-5958
53. Hupp, T. R., and Lane, D. P. (1994) Allosteric activation of latent p53 tetramers. Curr. Biol. 4, 865-875
54. Prives, C., and Hall, P. A. (1999) The p53 pathway. J. Pathol. 187, 112-126
55. Tang, Y., Zhao, W., Chen, Y., Zhao, Y., and Gu, W. (2008) Acetylation is indispensable for p53 activation. Cell 133, 612-626
56. Mellert, H., Sykes, S. M., Murphy, M. E., and McMahon, S. B. (2007) The ARF/oncogene pathway activates p53 acetylation within the DNA binding domain. Cell Cycle 6, 1304-1306
57. Sykes, S. M., Mellert, H. S., Holbert, M. A., Li, K., Marmorstein, R., Lane, W. S., and McMahon, S. B. (2006) Acetylation of the p53 DNA-binding domain regulates apoptosis induction. Mol. Cell 24, 841-851
58. Choudhary, C., Kumar, C., Gnad, F., Nielsen, M. L., Rehman, M., Walther, T. C., Olsen, J. V., and Mann, M. (2009) Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science 325, 834-840
59. Zhao, S., Xu, W., Jiang, W., Yu, W., Lin, Y., Zhang, T., Yao, J., Zhou, L., Zeng, Y., Li, H., Li, Y., Shi, J., An, W., Hancock, S. M., He, F., Qin, L., Chin, J., Yang, P., Chen, X., Lei, Q., Xiong, Y., and Guan, K. L. (2010) Regulation of cellular metabolism by protein lysine acetylation. Science 327, 1000-1004
60. Mellert, H. S., Stanek, T. J., Sykes, S. M., Rauscher, F. J. 3rd, Schultz, D. C., and McMahon, S. B. (2011) Deacetylation of the DNA-binding domain regulates p53-mediated apoptosis. J. Biol. Chem. 286(6), 4264-4270
61. Luo, J., Li, M., Tang, Y., Laszkowska, M., Roeder, R. G., and Gu, W. (2004) Acetylation of p53 augments its site-specific DNA binding both in vitro and in vivo. Proc. Natl. Acad. Sci. U.S.A. 101(8), 2259-2264
62. Kawaguchi, Y., Ito, A., Appella, E., and Yao, T. P. (2006) Charge modification at multiple C-terminal lysine residues regulates p53 oligomerization and its nucleus-cytoplasm trafficking. J. Biol. Chem. 281(3), 1394-1400
63. Yamaguchi, H., Woods, N. T., Piluso, L. G., Lee, H. H., Chen, J., Bhalla, K. N., Monteiro, A., Liu, X., Hung, M. C., and Wang, H. G. (2009) p53 acetylation is crucial for its transcription-independent proapoptotic functions. J. Biol. Chem. 284(17), 11171-11183
64. Itahana, Y., Ke, H., and Zhang, Y. (2009) p53 oligomerization is essential for its C-terminal lysine acetylation. J. Biol. Chem. 284, 5158-5164
65. Chan, W. M., Mak, M. C., Fung, T. K., Lau, A., Siu, W. Y., and Poon, R. Y. (2006) Ubiquitination of p53 at multiple sites in the DNA-binding domain. Mol. Cancer Res. 4, 15-25
66. Le Cam, L., Linares, L. K., Paul, C., Julien, E., Lacroix, M., Hatchi, E., Triboulet, R., Bossis, G., Shmueli, A., Rodriguez, M. S., Coux, O., and Sardet, C. (2006) E4F1 is an atypical ubiquitin ligase that modulates p53 effector functions independently of degradation. Cell 127, 775-788
67. Kruse, J. P., and Gu, W. (2009) MSL2 promotes Mdm2-independent cytoplasmic localization of p53. J. Biol. Chem. 284, 3250-3263
68. Marchenko, N. D., Hanel, W., Li, D., Becker, K., Reich, N., and Moll, U. M. (2010) Stress-mediated nuclear stabilization of p53 is regulated by ubiquitination and importin-alpha3 binding. Cell Death Differ. 17, 255-267
69. Nie, L., Sasaki, M., and Maki, C. G. (2007) Regulation of p53 nuclear export through sequential changes in conformation and ubiquitination. J. Biol. Chem. 282, 14616-14625
70. Jansson, M., Durant, S. T., Cho, E. C., Sheahan, S., Edelmann, M., Kessler, B., and La Thangue, N. B. (2008) Arginine methylation regulates the p53 response. Nat. Cell Biol. 10, 1431-1439
71. Chuikov, S., Kurash, J. K., Wilson, J. R., Xiao, B., Justin, N., Ivanov, G. S., McKinney, K., Tempst, P., Prives, C., Gamblin, S. J., Barlev, N. A., and Reinberg, D. (2004) Regulation of p53 activity through lysine methylation. Nature 432, 353-360
72. Huang, J., Perez-Burgos, L., Placek, B. J., Sengupta, R., Richter, M., Dorsey, J. A., Kubicek, S., Opravil, S., Jenuwein, T., and Berger, S. L. (2006) Repression of p53 activity by Smyd2-mediated methylation. Nature 444, 629-632
73. Shi, X., Kachirskaia, I., Yamaguchi, H., West, L. E., Wen, H., Wang, E. W., Dutta, S., Appella, E., and Gozani, O. (2007) Modulation of p53 function by SET8-mediated methylation at lysine 382. Mol. Cell 27, 636-646
74. Ivanov, G. S., Ivanova, T., Kurash, J., Ivanov, A., Chuikov, S., Gizatullin, F., Herrera-Medina, E. M., Rauscher, F. 3rd, Reinberg, D., and Barlev, N. A. (2007) Methylation-acetylation interplay activates p53 in response to DNA damage. Mol. Cell. Biol. 27(19), 6756-6769
75. Huang, J., Dorsey, J., Chuikov, S., Pérez-Burgos, L., Zhang, X., Jenuwein, T., Reinberg, D., and Berger, S. L. (2010) G9a and Glp methylate lysine 373 in the tumor suppressor p53. J. Biol. Chem. 285(13), 9636-9641
76. Young, N. L., Dimaggio, P. A., and Garcia, B. A. (2010) The significance, development and progress of high-throughput combinatorial histone code analysis. Cell. Mol. Life Sci. 67, 3983-4000
77. Altelaar, A. F., Munoz, J., and Heck, A. J. (2013) Next-generation proteomics: towards an integrative view of proteome dynamics. Nat. Rev. Genet. 14, 35-48
78. Debbas, M., and White, E. (1993) Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. Genes Dev. 7, 546-554
79. Lowe, S. W., and Ruley, H. E. (1993) Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis. Genes Dev. 7, 535-545
80. Zhang, X., Turnell, A. S., Gorbea, C., Mymryk, J. S., Gallimore, P. H., and Grand, R. J. (2004) The targeting of the proteasomal regulatory subunit S2 by adenovirus E1A causes inhibition of proteasomal activity and increased p53 expression. J. Biol. Chem. 279(24), 25122-25133
81. White, E. (2001) Regulation of the cell cycle and apoptosis by the oncogenes of adenovirus. Oncogene 20, 7836-7846
82. Frisch, S. M., and Mymryk, J. S. (2002) Adenovirus-5 E1A: paradox and paradigm. Nat. Rev. Mol. Cell Biol. 3, 441-452
83. Querido, E., Marcellus, R. C., Lai, A., Charbonneau, R., Teodoro, J. G., Ketner, G., and Branton, P. E. (1997) Regulation of p53 levels by the E1B 55-kilodalton protein and E4orf6 in adenovirus-infected cells. J. Virol. 71, 3788-3798
84. Querido, E., Morrison, M. R., Chu-Pham-Dang, H., Thirlwell, S. W., Boivin, D., and Branton, P. E. (2001) Identification of three functions of the adenovirus E4orf6 protein that mediate p53 degradation by the E4orf6- E1B55K complex. J. Virol. 75, 699-709
85. Harada, J. N., Shevchenko, A., Shevchenko, A., Pallas, D. C., and Berk, A. J. (2002) Analysis of the adenovirus E1B-55K-anchored proteome reveals its link to ubiquitination machinery. J. Virol. 76, 9194-9206
86. Luo, K., Ehrlich, E., Xiao, Z., Zhang, W., Ketner, G., and Yu, X. F. (2007) Adenovirus E4orf6 assembles with Cullin5-ElonginB-ElonginC E3 ubiquitin ligase through an HIV/SIV Vif-like BC-box to regulate p53. FASEB J. 21, 1742-1750
87. Woo, J. L., and Berk, A. J. (2007) Adenovirus ubiquitin-protein ligase stimulates viral late mRNA nuclear export. J. Virol. 81, 575-587
88. Blanchette, P., Cheng, C. Y., Yan, Q., Ketner, G., Ornelles, D. A., Dobner, T., Conaway, R. C., Conaway, J. W., and Branton, P. E. (2004) Both BC-box motifs of adenovirus protein E4orf6 are required to efficiently assemble an E3 ligase complex that degrades p53. Mol. Cell. Biol. 24(21), 9619-9629
89. Schwartz, R. A., Lakdawala, S. S., Eshleman, H. D., Russell, M. R., Carson, C. T., and Weitzman, M. D. (2008) Distinct requirements of adenovirus E1b55K protein for degradation of cellular substrates. J. Virol. 82, 9043-9055
90. Cardoso, F. M., Kato, S. E., Huang, W., Flint, S. J., and Gonzalez, R. A. (2008) An early function of the adenoviral E1B 55 kDa protein is required for the nuclear relocalization of the cellular p53 protein in adenovirusinfected normal human cells. Virology 378, 339-346
91. O'Shea, C. C., Johnson, L., Bagus, B., Choi, S., Nicholas, C., Shen, A., Boyle, L., Pandey, K., Soria, C., Kunich, J., Shen, Y., Habets, G., Ginzinger, D., and McCormick, F. (2004) Late viral RNA export, rather than p53 inactivation, determines ONYX-015 tumor selectivity. Cancer Cell 6, 611-623
92. Hobom, U., and Dobbelstein, M. (2004) E1B-55-kilodalton protein is not required to block p53-induced transcription during adenovirus infection. J. Virol. 78, 7685-7697
93. Miller, D. L., Rickards, B., Mashiba, M., Huang, W., and Flint, S. J. (2009) The adenoviral E1B 55-kilodalton protein controls expression of immune response genes but not p53-dependent transcription. J. Virol. 83, 3591-3603
94. Kato, S. E., Huang, W., and Flint, S. J. (2011) Role of the RNA recognition motif of the E1B 55 kDa protein in the adenovirus type 5 infectious cycle. Virology 417, 9-17
95. He, T. C., Zhou, S., da Costa, L. T., Yu, J., Kinzler, K. W., and Vogelstein, B. (1998) A simplified system for generating recombinant adenoviruses. Proc. Natl. Acad. Sci. U.S.A. 95(5), 2509-2514
96. Harlow, E., Crawford, L. V., Pim, D. C., and Williamson, N. M. (1981) Monoclonal antibodies specific for simian virus 40 tumor antigens. J. Virol. 39, 861-869
97. Ball, R. K., Siegl, B., Quellhorst, S., Brandner, G., and Braun, D. G. (1984) Monoclonal antibodies against simian virus 40 nuclear large T tumor antigen: epitope mapping, papova virus cross reaction and cell surface staining. EMBO J. 3, 1485-1491
98. Banks, L., Matlashewski, G., and Crawford, L. (1986) Isolation of humanp53- specific monoclonal antibodies and their use in the studies of human p53 expression. Eur. J. Biochem. 159, 529-534
99. Gonzalez, R. A., and Flint, S. J. (2002) Effects of mutations in the adenoviral E1B 55 kDa protein coding sequence on viral late mRNA metabolism. J. Virol. 76, 4507-4519
100. Rasband, W. S. (1997-2013) ImageJ. U. S. National Institutes of Health, Bethesda, Maryland, USA, http://imagej.nih.gov/ij/.
101. Shevchenko, A., Tomas, H., Havlis, J., Olsen, J. V., and Mann, M. (2006) In-gel digestion for mass spectrometric characterization of proteins and proteomes. Nat. Protoc. 1, 2856-2860
102. Rappsilber, J., Ishihama, Y., and Mann, M. (2003) Stop and go extraction tips for matrix-assisted laser desorption/ionization, nanoelectrospray, and LC/MS sample pretreatment in proteomics. Anal. Chem. 75, 663-670
103. Beausoleil, S. A., Villén, J., Gerber, S. A., Rush, J., and Gygi, S. P. (2006) A probability-based approach for high-throughput protein phosphorylation analysis and site localization. Nat. Biotechnol. 24, 1285-1292
104. Jänicke, R. U., Graupner, V., Budach, W., and Essmann, F. (2009) The do's and don'ts of p53 isoforms. Biol. Chem. 390, 951-963
105. Hollstein, M., and Hainaut, P. (2010) Massively regulated genes: the example of TP53. J. Pathol. 220, 164-173
106. Gannon, J. V., Greaves, R., Iggo, R., and Lane, D. P. (1990) Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form. EMBO J. 9(5), 1595-1602
107. Arriola, E. L., Lopez, A. R., and Chresta, C. M. (1999) Differential regulation of p21waf-1/cip-1 and Mdm2 by etoposide: etoposide inhibits the p53- Mdm2 autoregulatory feedback loop. Oncogene 18, 1081-1091
108. Karpinich, N. O., Tafani, M., Rothman, R. J., Russo, M. A., and Farber, J. L. (2002) The course of etoposide-induced apoptosis from damage to DNA and p53 activation to mitochondrial release of cytochrome c. J. Biol. Chem. 277(19), 16547-16552
109. Chalkley, G. E., Knowles, P. P., Whitehead, P. C., and Coffer, A. I. (1994) Biochemical characterisation of purified human wild-type p53 overexpressed in insect cells. Eur. J. Biochem. 221, 167-175
110. Joerger, A. C., and Fersht, A. R. (2007) Structure-function-rescue: the diverse nature of common p53 cancer mutants. Oncogene 26, 2226-2242
111. Olivier, M., Hollstein, M., and Hainaut, P. (2010) TP53 mutations in human cancers: origins, consequences, and clinical use. Cold Spring Harb. Perspect. Biol. 2(1), a001008
112. Rivlin, N., Brosh, R., Oren, M., and Rotter, V. (2011) Mutations in the p53 tumor suppressor gene: important milestones at the various steps of tumorigenesis. Genes Cancer 2, 466-474
113. Nesvizhskii, A. I., Keller, A., Kolker, E., and Aebersold, R. (2003) A statistical model for identifying proteins by tandem mass spectrometry. Anal. Chem. 75, 4646-4658
114. Keller, A., Nesvizhskii, A. I., Kolker, E., and Aebersold, R. (2002) Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal. Chem. 74, 5383-5392
115. Uhle, S., Medalia, O., Waldron, R., Dumdey, R., Henklein, P., Bech- Otschir, D., Huang, X., Berse, M., Sperling, J., Schade, R., and Dubiel, W. (2003) Protein kinase CK2 and protein kinase D are associated with the COP9 signalsome. EMBO J. 22, 1302-1312
116. Lee, E. W., Lee, M. S., Camus, S., Ghim, J., Yang, M. R., Oh, W., Ha, N. C., Lane, D. P., and Song, J. (2009) Differential regulation of p53 and p21 by MKRN1 E3 ligase controls cell cycle arrest and apoptosis, EMBO J. 28, 2100-2113
117. Rodriguez, M. S., Desterro, J. M., Lain, S., Lane, D. P., and Hay, R. T. (2000) Multiple C-terminal lysine residues target p53 for ubiquitin proteasome- mediated degradation. Mol. Cell. Biol. 20(22), 8458-8467
118. Nakamura, S., Roth, J. A., and Mukhopadhyay, T. (2000) Multiple lysine mutations in the C-terminal domain of p53 interfere with MDM2-dependent protein degradation and ubiquitination. Mol. Cell. Biol. 20, 9391-9398
119. Li, M., Luo, J., Brooks, C. L., and Gu, W. (2002) Acetylation of p53 inhibits its ubiquitination by Mdm2. J. Biol. Chem. 277(52), 50607-50611
120. Ito, A., Kawaguchi, Y., Lai, C. H., Kovacs, J. J., Higashimoto, Y., Appella, E., and Yao, T. P. (2002) MDM2-HDAC1-mediated deacetylation of p53 is required for its degradation. EMBO J. 21, 6236-6245
121. Li, M., Brooks, C. L., Wu-Baer, F., Chen, D., Baer, R., and Gu, W. (2003) Mono- versus polyubiquitination: differential control of p53 fate by Mdm2. Science 302, 1972-1975
122. Tang, Y., Luo, J., Zhang, W., and Gu, W. (2006) Tip60-dependent acetylation of p53 modulates the decision between cell-cycle arrest and apoptosis. Mol. Cell 24, 827-839
123. Gu, W., and Roeder, R. G. (1997) Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90, 595-606
124. Sakaguchi, K., Herrera, J. E., Saito, S., Miki, T., Bustin, M., Vassilev, A., Anderson, C. W., and Appella, E. (1998) DNA damage activates p53 through a phosphorylation-acetylation cascade. Genes Dev. 12, 2831-2841
125. Liu, L., Scolnick, D. M., Trievel, R. C., Zhang, H. B., Marmorstein, R., Halazonetis, T. D., and Berger, S. L. (1999) p53 sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage. Mol. Cell. Biol. 19(2), 1202-1209
126. Moll, U. M., and Petrenko, O. (2003) The MDM2-p53 interaction. Mol. Cancer Res. 1, 1001-1008
127. Ferreon, J. C., Lee, C. W., Arai, M., Martinez-Yamout, M. A., Dyson, H. J., and Wright, P. E. (2009) Cooperative regulation of p53 by modulation of ternary complex formation with CBP/p300 and HDM2. Proc. Natl. Acad. Sci. U.S.A. 106(16), 6591-6596
128. Kitayner, M., Rozenberg, H., Kessler, N., Rabinovich, D., Shaulov, L., Haran, T. E., and Shakked, Z. (2006) Structural basis of DNA recognition by p53 tetramers. Mol. Cell 22, 741-753
129. Chen, Y., Dey, R., and Chen, L. (2010) Crystal structure of the p53 core domain bound to a full consensus site as a self-assembled tetramer. Structure 18, 246-256
130. Cho, Y., Gorina, S., Jeffrey, P. D., and Pavletich, N. P. (1994) Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science 265, 346-355
131. Kato, S., Han, S. Y., Liu, W., Otsuka, K., Shibata, H., Kanamaru, R., and Ishioka, C. (2003) Understanding the function-structure and functionmutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis. Proc. Natl. Acad. Sci. U.S.A. 100(14), 8424-8429
132. Hancock, J. F. (1992) COS cell expression. Methods Mol. Biol. 8, 153-158
133. Reich, N. C., Oren, M., and Levine, A. J. (1983) Two distinct mechanisms regulate the levels of a cellular tumor antigen, p53. Mol. Cell. Biol. 3, 2143-2150
134. Joubel, A., Chalkley, R. J., Medzihradszky, K. F., Hondermarck, H., and Burlingame, A. L. (2009) Identification of new p53 acetylation sites in COS-1 cells. Mol. Cell. Proteomics 8, 1167-1173
135. Danks, M. K., Whipple, D. O., McPake, C. R., Lu, D., and Harris, L. C. (1998) Differences in epitope accessibility of p53 monoclonal antibodies suggest at least three conformations or states of protein binding of p53 protein in human tumor cell lines. Cell Death Differ. 5, 678-686
136. Wang, P. L., Sait, F., and Winter, G. (2001) The "wildtype" conformation of p53: epitope mapping using hybrid proteins. Oncogene 20, 2318-2324
137. Sakaguchi, K., Sakamoto, H., Lewis, M. S., Anderson, C. W., Erickson, J. W., Appella, E., and Xie, D. (1997) Phosphorylation of serine 392 stabilizes the tetramer formation of tumor suppressor protein p53. Biochemistry 36, 10117-10124
138. Sims, R. J., 3rd, and Reinberg, D. (2008) Is there a code embedded in proteins that is based on post-translational modifications? Nat. Rev. Mol. Cell Biol. 9, 815-820
139. West, L. E., and Gozani, O. (2011) Regulation of p53 function by lysine methylation. Epigenomics 3, 361-369
140. Smith, L. M., Kelleher, N. L.; Consortium for Top Down Proteomics. (2013) Proteoform: a single term describing protein complexity. Nat. Methods 10, 186-187
141. Ahlf, D. R., Compton, P. D., Tran, J. C., Early, B. P., Thomas, P. M., and Kelleher, N. L. (2012) Evaluation of the compact high-field orbitrap for top-down proteomics of human cells. J. Proteome Res. 11, 4308-4314
142. Tipton, J. D., Tran, J. C., Catherman, A. D., Ahlf, D. R., Durbin, K. R., Lee, J. E., Kellie, J. F., Kelleher, N. L., Hendrickson, C. L., and Marshall, A. G. (2012) Nano-LC FTICR tandem mass spectrometry for top-down proteomics: routine baseline unit mass resolution of whole cell lysate proteins up to 72 kDa. Anal. Chem. 84, 2111-2117
143. Michalski, A., Damoc, E., Lange, O., Denisov, E., Nolting, D., Müller, M., Viner, R., Schwartz, J., Remes, P., Belford, M., Dunyach, J. J., Cox, J., Horning, S., Mann, M., and Makarov, A. (2012) Ultra high resolution linear ion trap Orbitrap mass spectrometer (Orbitrap Elite) facilitates top down LC MS/MS and versatile peptide fragmentation modes. Mol. Cell. Proteomics 11(3), O111.013698